![glp 1 antibody Glutazumab, a novel long-lasting GLP-1/anti-GLP-1R fusion protein, exerts anti-diabetic effects through targeting dual receptor binding sites 50 conjugated to Bovine Serum Albumin. Anti-GLP-1 antibody [EPR4042-1] (ab108443) |](https://ars.els-cdn.com/content/image/1-s2.0-S0006295218300297-fx1.jpg)
![glp 1 antibody Glutazumab, a novel long-lasting GLP-1/anti-GLP-1R fusion protein, exerts anti-diabetic effects through targeting dual receptor binding sites 50 conjugated to Bovine Serum Albumin. Anti-GLP-1 antibody [EPR4042-1] (ab108443) |](https://resources.rndsystems.com/images/products/antibody/mab10473_human-glucagon-mab-clone-2622b-immunohistochemistry-3092020155750.jpg)
![glp 1 antibody Glutazumab, a novel long-lasting GLP-1/anti-GLP-1R fusion protein, exerts anti-diabetic effects through targeting dual receptor binding sites 50 conjugated to Bovine Serum Albumin. Anti-GLP-1 antibody [EPR4042-1] (ab108443) |](https://resources.rndsystems.com/categoryimages/novus_antibodies.jpg)
![glp 1 antibody Glutazumab, a novel long-lasting GLP-1/anti-GLP-1R fusion protein, exerts anti-diabetic effects through targeting dual receptor binding sites 50 conjugated to Bovine Serum Albumin. Anti-GLP-1 antibody [EPR4042-1] (ab108443) |](https://media.scbt.com/product/glp-1r-antibody-d-6-western-blotting_39_49_b_394984.jpg)
glp 1 antibody
Shipping Estimate
glp 1 antibody Glutazumab, a novel long-lasting GLP-1/anti-GLP-1R fusion protein, exerts anti-diabetic effects through targeting dual receptor binding sites 50 conjugated to Bovine Serum Albumin. Anti-GLP-1 antibody [EPR4042-1] (ab108443) |
EUR23.09
EUR46.09
Pay in 4 interest-free payments of $5.77 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
![glp 1 antibody Glutazumab, a novel long-lasting GLP-1/anti-GLP-1R fusion protein, exerts anti-diabetic effects through targeting dual receptor binding sites 50 conjugated to Bovine Serum Albumin. Anti-GLP-1 antibody [EPR4042-1] (ab108443) |](https://content.abcam.com/products/images/glp-1-antibody-epr4042-1-ab108443--immunocytochemistry-immunofluorescence-img108423.jpg)
![glp 1 antibody Glutazumab, a novel long-lasting GLP-1/anti-GLP-1R fusion protein, exerts anti-diabetic effects through targeting dual receptor binding sites 50 conjugated to Bovine Serum Albumin. Anti-GLP-1 antibody [EPR4042-1] (ab108443) |](https://content.abcam.com/products/images/glp-1r-antibody-epr21819-ab218532--immunohistochemistry-frozen-sections-img34413.jpg)
![glp 1 antibody Glutazumab, a novel long-lasting GLP-1/anti-GLP-1R fusion protein, exerts anti-diabetic effects through targeting dual receptor binding sites 50 conjugated to Bovine Serum Albumin. Anti-GLP-1 antibody [EPR4042-1] (ab108443) |](https://content.abcam.com/products/images/glp-1-antibody-ab22625--immunohistochemistry-formalin-pfa-fixed-paraffin-embedded-sections-img102413.jpg)
![glp 1 antibody Glutazumab, a novel long-lasting GLP-1/anti-GLP-1R fusion protein, exerts anti-diabetic effects through targeting dual receptor binding sites 50 conjugated to Bovine Serum Albumin. Anti-GLP-1 antibody [EPR4042-1] (ab108443) |](https://cdn11.bigcommerce.com/s-jeqpi38dm3/images/stencil/1280x1280/products/1847/882/622-MAB2814-SP__78544__49639.1655907578.jpg?c=1?imbypass=on)
